Two plus One: Combination Therapy Tri-systems Involving Two Membrane-Disrupting Antimicrobial Macromolecules and Antibiotics.

Shao, Zeyu; Wulandari, Erna; Lin, Ruby C Y; Xu, Jiangtao; Liang, Kang; Wong, Edgar H H

Shao, Zeyu; Wulandari, Erna; Lin, Ruby C Y; Xu, Jiangtao; Liang, Kang; Wong, Edgar H H.

Afiliação

Shao Z; Australian Centre for NanoMedicine (ACN), School of Chemical Engineering, University of New South Wales, Sydney, New South Wales 2052, Australia.
Wulandari E; Australian Centre for NanoMedicine (ACN), School of Chemical Engineering, University of New South Wales, Sydney, New South Wales 2052, Australia.
Lin RCY; Sydney Medical School, University of Sydney, Sydney, New South Wales 2006, Australia.
Xu J; Centre for Infectious Diseases and Microbiology, Westmead Institute for Medical Research, Westmead, New South Wales 2145, Australia.
Liang K; School of Medical Sciences, University of New South Wales, Sydney, New South Wales 2052, Australia.
Wong EHH; Australian Centre for NanoMedicine (ACN), School of Chemical Engineering, University of New South Wales, Sydney, New South Wales 2052, Australia.

ACS Infect Dis ; 8(8): 1480-1490, 2022 08 12.

Article em En | MEDLINE | ID: mdl-35771275

Assuntos

Antibacterianos; Anti-Infecciosos; Animais; Camundongos; Antibacterianos/farmacologia; Antibacterianos/uso terapêutico; Doxiciclina; Sinergismo Farmacológico; Testes de Sensibilidade Microbiana; Polímeros; Rifampina/farmacologia

Palavras-chave

biocompatibility; controlled radical polymerization; multidrug-resistant bacteria; selectivity index; synergy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anti-Infecciosos / Antibacterianos Limite: Animals Idioma: En Revista: ACS Infect Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google